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Persisters are phenotypic variants present within
isogenic bacterial populations that exhibit extreme
tolerance toward antibiotic stress. We previously
elucidated a mechanistic pathway by which Escher-
ichia coli persisters to ofloxacin form in response to a
carbon source transition. Here, we examine how per-
sisters to ampicillin form from the same metabolic
stress and identify the shared and unique elements
of the persister formation pathways. We discovered
that diauxie-dependent formation of ampicillin per-
sisters required RelA and that loss of clpA, ssrA, or
smpB eliminated persister formation through relaxa-
tion of the stringent response. Further, we found that
tolerance to ampicillin was achieved through broad
inhibition of peptidoglycan biosynthesis, as evi-
denced by the formation of persisters to antibiotics
that target enzymes in different areas of that biosyn-
thetic pathway. Interestingly, ppGpp was required
for formation of both ampicillin and ofloxacin per-
sisters, and we demonstrated that higher synthesis
of the alarmone was needed to increase persisters
to ampicillin compared to ofloxacin. Further, we
found trans-translation and DksA to be common me-
diators of both pathways, whereas ClpA was unique
for ampicillin persisters and nucleoid-associated
proteins were unique for ofloxacin persisters. These
results highlight the need to consider an antibiotic’s
mode of action when analyzing persister formation,
demonstrate that individual stresses can produce
persister heterogeneity, and emphasize the impor-
tance of identifying each respective pathway to
identify common mediators that possess the most
therapeutic potential to combat persisters.
INTRODUCTION
Persisters comprise a transient phenotypic subpopulation of
bacterial cultures that exhibits tolerance to supra-lethal concen-
trations of antibiotics. Persisters are distinct from antibiotic-
resistant cells in that there is no genetic mutation allowing
them to proliferate in the presence of antibiotics, but rather
they exist in a favorable phenotypic state at the time of treatment
that allows survival [1]. Persisters have been implicated in2090 Current Biology 25, 2090–2098, August 17, 2015 ª2015 Elseviechronic infections and are believed to be responsible for the
recalcitrance of biofilm infections [1].
Persister tolerances havemainly been attributed to entry into a
non-growing physiological state where essential targets that
antibiotics corrupt are inactive. Supportive evidence for this
mechanism originated from single-cell microfluidic studies
where non- or slow-growing cells survived treatment [2, 3].
According to this model, persisters should exhibit multidrug
tolerance and possess largely uniform antibiotic susceptibility
[1, 4]. However, when identical cultures are treated with
different antibiotics, it is not uncommon to observe different
persister levels [5–9]. For example, Vega and colleagues showed
that higher indole concentrations increased persisters to
different classes of antibiotics to varying degrees [9]. Therefore,
persister populations should be regarded as heterogeneous
[3, 4, 6, 10, 11], where single-cell variability in cellular processes
generates physiological diversity. Identification of mechanisms
responsible for this drug-specific heterogeneity will provide
knowledge of common mediators that can be used to broadly
impair persister formation.
We previously discovered an ofloxacin persister formation
pathway triggered by a carbon source transition, where the
metabolic TA module, ppGpp-SpoT, DksA, and nucleoid-
associated proteins (NAPs) were required for fluoroquinolone
tolerance [12]. We also showed that carbon source transitions
stimulated ampicillin persister formation, but the initial results
suggested that distinct formation mechanisms were responsible
for ampicillin and ofloxacin persisters. Here, we elucidated the
ampicillin persister formation pathway by studying diauxic batch
growth of E. coli and using genetic perturbations, metabolite
quantification, quantitative PCR (qPCR), and biochemical as-
says. We linked glucose exhaustion to a stringent response
that required RelA, trans-translation, and ClpA to broadly inhibit
peptidoglycan biosynthesis (PGB), which contains ampicillin’s
primary target. We found ppGpp to be an important mediator
of both ofloxacin and ampicillin persister formation and
demonstrated that tolerance to these different antibiotics was
engendered by different ppGpp levels. With these results, we
provided evidence that a single metabolic stress triggered
antibiotic-specific persister formation pathways and identified
common mediators that could be utilized as targets to inhibit
those processes.
RESULTS
Diauxic Shifts Stimulate Ampicillin Persister Formation
We have previously shown that carbon source shifts from
glucose to a variety of secondary carbon sources stimulatedr Ltd All rights reserved
Figure 1. Diauxic Shift Stimulates Ampicillin
Persister Formation
(A) Diauxic growth results in significant persister
formation, whereas non-diauxic growth does not.
(B) Growth on fumarate is not responsible for
persister formation in glucose-fumarate, as evi-
denced by sole fumarate control.
(C) Cells grown in glucose-fumarate were treated
with either ampicillin, ofloxacin, or co-treated. Co-
treatment had significantly fewer persisters than
either sole treatment.
Error bars indicate SEM. Significance was
assessed using the null hypothesis that the
mean CFU/mL in two samples was equal. See also
Table S1.ofloxacin and ampicillin persister formation [12]. Interestingly,
we observed that all diauxic transitions stimulated ofloxacin
persister formation, whereas ampicillin persister formation was
not observed in certain diauxic conditions, which suggested
that the formation pathways were different. Previously, we eluci-
dated the ofloxacin persister formation pathway [12], whereas,
here, we sought to identify how diauxie generated ampicillin per-
sisters. We focused on diauxic growth from glucose to fumarate
since it elicited the strongest persister formation response, and
we used growth on glucose as the sole carbon source and
growth on glucose to fructose, which is non-diauxic and not
co-utilized with glucose, as controls [12]. Persister measure-
ments were taken during growth on glucose (0.02 optical density
600 [OD600]) and after glucose exhaustion and growth on the
secondary substrate, except for the sole glucose control that
grew on glucose throughout (0.12 OD600) (Table S1). During
growth on glucose, persister levels were the same independent
of the secondary carbon source present (Figure 1A). Persister
measurements during growth on the secondary carbon source
showed a statistically significant 25-fold increase in persisters
for glucose-fumarate cultures and no increase for glucose-fruc-
tose cultures when compared to persister levels in glucose-only
cultures at the same OD600.
To establish that persister formation was due to the transition
from glucose to fumarate and not from slower growth on fuma-
rate, we took persister measurements at the same cell densities
during growth on sole fumarate (Figure 1B). The persister levels
for the fumarate-only cultures were comparable to persister
levels for glucose-only cultures but were 75-fold lower and sta-
tistically different from those for the glucose-fumarate cultures.
These results demonstrated that the persister formation wasCurrent Biology 25, 2090–2098, August 17, 2015 ªthe result of the carbon source transition
and not due to growth on fumarate.
We next examined whether the ampi-
cillin and ofloxacin persisters formed
originated from a single multidrug-
tolerant population by co-treating cul-
tures. We observed that prior to the
transition, persister levels were all
comparable, whereas after the transition,
the co-treated persister population was
significantly reduced 10-fold compared
to the persister populations in the soletreatments (Figure 1C). This suggested that the majority of ampi-
cillin and ofloxacin persisters formed from the transition (90%)
were in independent subpopulations where they were tolerant to
one antibiotic but not the other. Further, these data provided
additional support that separate mechanisms existed for
ampicillin and ofloxacin persister formation from this metabolic
stress.
Addition of cAMP and Serine Hydroxamate Stimulate
Ampicillin Persister Formation
We next evaluated the roles of diauxie mediators in ampicillin
persister formation. The two major signaling pathways activated
during glucose limitation, catabolite de-repression and stringent
response activation [13], cannot be eliminated in our growth con-
ditions [12] since DcyaA and Dcrp prevent resumption of growth
on the secondary carbon source, and DrelADspoT and DdksA
are auxotrophic [13]. Therefore, we tested how synthetically
increasing levels of cyclic AMP (cAMP) and ppGpp affect ampi-
cillin persister formation.
Addition of cAMP generated a statistically significant10-fold
increase in persisters when compared to the untreated wild-
type culture (Figure 2A). In a Dcrp mutant, addition of cAMP
failed to increase persister levels, which suggested that
cAMP-CRP has the ability to signal ampicillin persister formation
(Figure 2B). However, we note that Dcrp persister levels in our
untreated control were higher than those of wild-type, which
could have masked modest induction of persistence from
cAMP. Notably, though, we did not observe a growth defect
upon cAMP addition to Dcrp as we did for wild-type (Fig-
ure S1A). Collectively, these data suggest that cAMP broadly
impacts wild-type physiology, including persistence, whereas2015 Elsevier Ltd All rights reserved 2091
Figure 2. cAMP and SHX Stimulates Ampi-
cillin Persister Formation
(A–D) Wild-type (A) persisters significantly in-
creased due to cAMP, whereas Dcrp (B) and DrelA
(C) did not.
(D) Persistence to ampicillin of wild-type exposed
to 1 mg/mL SHX, 50 mg/mL CAM, or no treatment.
Error bars indicate SEM. Significance was as-
sessed using the null hypothesis that the mean
CFU/mL in two samples was equal. See also
Figure S1.the same cannot be said for Dcrp. We previously discovered
cAMP-triggered formation of ofloxacin persisters was elimi-
nated in DrelADspoT [12], but testing this mutant requires amino
acid (aa) supplementation, and in media with aa, we observed
no ampicillin persister formation in response to cAMP (Fig-
ure S1B). However, we tested DrelA, which does not require
aa supplementation, and observed that persister formation
was eliminated in response to cAMP (Figure 2C), suggesting a
role for ppGpp in ampicillin persister formation downstream of
cAMP-CRP.
We investigated whether ppGpp, independent of cAMP-
CRP, can stimulate ampicillin persister formation with the use
of serine hydroxamate (SHX), which rapidly increases ppGpp
[14]. Since SHX results in growth arrest (Figure S1C), which
may increase antibiotic tolerance [12, 15], as a control
we used chloramphenicol (CAM) since it is also bacteriostatic
but does not increase ppGpp [16] (Figure S1C). SHX generated
a statistically significant 14-fold increase in ampicillin per-
sisters, whereas CAM failed to stimulate persister formation
(Figure 2D). These results demonstrated that increased ppGpp
levels induced ampicillin persister formation, whereas bacterio-
static inhibition of translation was insufficient. This contrasts
with ofloxacin persister formation under analogous conditions
where bacteriostatic inhibition of translation was sufficient to
stimulate 100-fold increase in persisters and SHX increased
persisters independent of ppGpp [12]. Since the stringent
response has been shown to affect the cAMP-CRP regulon
[13], we tested whether SHX-mediated ampicillin persister for-
mation was cAMP dependent but found that SHX formed as
many persisters in DcyaA as wild-type (Figure S1D). Unlike
ofloxacin persister formation where two pathways existed,
cAMP-ppGpp dependent and growth-arrest dependent [12],
data presented here suggested the existence of only one ampi-
cillin pathway.2092 Current Biology 25, 2090–2098, August 17, 2015 ª2015 Elsevier Ltd All rights reservedStringent Response at the Carbon
Transition Is Required for Persister
Formation
The results from the small molecule
studies guided us to analyze how SHX
triggered persister formation and to apply
this knowledge to further understand
the diauxie-dependent pathway. SHX in-
hibits tRNASer aminoacylation causing
an accumulation of uncharged tRNASer
and activation of RelA-dependent ppGpp
synthesis [14]. Given this and that RelAcontributes to the stringent response during diauxie [13], we
measured persisters prior to and after glucose exhaustion for
DrelA, which removed persister formation (Figure 3A). The com-
plementedDrelA strain restored persister formation (Figure S2C),
confirming that RelA is required for ampicillin persister formation.
In addition to stimulating the stringent response [14], SHX
treatment results in translational stalling and activation of
trans-translation [17]. Trans-translation is a quality control mech-
anism that requires SsrA and SmpB and is activated under
several stresses including aa and glucose starvation [18]. Conse-
quently, we measured persisters prior to and after glucose
exhaustion for DssrA and DsmpB, which both removed persister
formation (Figures 3B and 3C). The complemented DssrA and
DsmpB strains restored persister formation (Figures S2E and
S2G), confirming that trans-translation is required for ampicillin
persister formation.
Trans-translation is responsible for clearing stalled ribosomes
as well as tagging nascent polypeptides for degradation. There-
fore, we wanted to assess these roles using the ssrA-DD allele,
where stalled ribosomes are cleared but tagged proteins are un-
able to interact or be degraded by proteases [19]. When DssrA
carrying a plasmid expressing ssrA-DD under its natural pro-
moter was tested, no persister formation was observed (Fig-
ure S2H). These data suggested that the capability to clear
stalled ribosomes is not enough to elicit ampicillin persister for-
mation and that degradation of tagged proteins and/or their
interaction with proteases may be important. In E. coli, ClpAP
and ClpXP are the most prominent and extensively studied
SsrA-degrading proteases [19]. Loss of the proteolytic subunit
ClpP (DclpP) or the chaperone subunit ClpX (DclpX) exhibited
an increase in persisters that was comparable to wild-type (Fig-
ures 3D and 3E). Interestingly, removal of the chaperone subunit
ClpA (DclpA) eliminated persister formation (Figure 3F). The
complemented DclpA strain restored formation (Figure S2J),
Figure 3. Trans-translation, ClpA, and RelA Are Required for
Persister Formation through the Stringent Response
(A–D) Persister formation occurred in wild-type, whereas DrelA (A), DssrA (B),
and DsmpB (C) eliminated persister formation.
Current Biology 25, 2090–suggesting that although ClpA is required for ampicillin persister
formation, it is not due to ClpAP activity since DclpP did not re-
move formation.
Lon can also degrade SsrA-tagged proteins [20] and has been
implicated in persistence through degradation of antitoxins
[2, 21]. We tested Dlon in our diauxic media and found that it
could not resume growth on fumarate after glucose exhaustion
(Figure S2K), which prevented assessment of the role of Lon in
our pathway. Single deletion strains of 11 toxins exhibited
persister formation that was indistinguishable from wild-type
(Figures S2L–S2V), and DppkDppx, which removes an essential
component of the Lon-TA pathway [2], failed to exhibit diauxie
due to co-utilization of glucose and fumarate (Figure S2W).
Collectively, these data demonstrate that none of the most likely
TA modules are solely responsible for ampicillin persister forma-
tion, which, we note, does not exclude the possibility that a
combination of toxins could be participating in the pathway
described here.
With RelA, trans-translation, and ClpA identified as pathway
participants, we sought to determine their interdependence.
Since ppGpp regulates the stringent response and is an impor-
tant mediator of persistence [2, 12, 22–24], we tested whether
trans-translation and ClpA contribute to persister formation
through the stringent response. We measured intracellular
ppGpp at the carbon source transition for wild-type, mutants
that significantly perturbed our pathway, and DclpX as a control.
We established that wild-type ppGpp levels increased 4-fold
during the transition compared to ppGpp levels when cells
were growing exponentially on glucose (Figures S3A–S3G),
which is similar to increases in ppGpp reported for glucose-suc-
cinate diauxie [25]. At the start of the transition, we found signif-
icantly lower ppGpp levels for DrelA and DssrA, whereas DclpA
and DclpX possessed analogous concentrations compared to
wild-type (Figures 3G and S3H). DrelA was expectedly deficient
in ppGpp production as RelA is a ppGpp synthase, and this
relaxed response during diauxie has been shown previously
[25]. Interestingly, DssrA also affected ppGpp synthesis during
the carbon source transition, suggesting a role for trans-transla-
tion in the stringent response. To measure stringent transcrip-
tional control, we monitored levels of 23S rRNA at the carbon
source transition using qPCR [26]. When levels of ppGpp are
high, transcription of rRNA is repressed in a strain with an intact
stringent response, whereas levels of rRNAwill be2- to 10-fold
higher in strains with impaired stringent responses [27, 28]. We
found that 23S rRNA expression was >2-fold higher and statisti-
cally different in DrelA, DssrA, and DclpA than wild-type at the(D–F)DclpP (D) andDclpX (E) exhibited similar persister formation to wild-type,
whereas DclpA (F) eliminated persister formation. Significance was assessed
using the null hypothesis that the mutant mean fold change in persisters was
equal to the wild-type fold change in persisters.
(G) ppGpp in wild-type, DrelA, DssrA, DclpA, and DclpX at the transition. DrelA
and DssrA showed statistically significant lower ppGpp than wild-type,
whereas ppGpp in DclpA and DclpX was indistinguishable from that of
wild-type.
(H) DrelA, DssrA, and DclpA showed statistically significant 2-fold higher
rRNA expression than wild-type, whereas DclpX rRNA was comparable to
wild-type. Significance was assessed using the null hypothesis that the mean
fold change of mutant to wild-type was equal to 1.
Error bars indicate SEM. See also Figures S2 and S3 and Table S1.
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start of the transition, whereas DclpX showed 23S rRNA expres-
sion comparable to wild-type (Figures 3H and S3I). These results
indicated that deletion of trans-translation or ClpA leads to
relaxed stringent control at the transition similar to cells without
RelA and that although ClpA does not alter ppGpp levels during
diauxie, it does play a role in transcriptional stringent control.
To further examine connections between trans-translation,
ClpA, and RelA, we used expression of the constitutively active
relA0 [29] in DssrA, DsmpB, and DclpA to determine whether
increasing ppGpp could restore persister formation. We relied
on promoter leakiness to express relA0 since this expression
level was able to complement the DrelA phenotype to that of
wild-type carrying an empty vector (Figures S3J and S3K). We
found that relA0 expression in DssrA and DsmpB restored
persister formation to levels comparable to that of wild-type,
which further supported that trans-translation acted through
ppGpp to form persisters (Figures S3L and S3M). For DclpA ex-
pressing relA0, persister formation was partially restored (Fig-
ure S3N). We also tested whether clpA overexpression could
restore persister levels in DrelA and found that it was unable to
do so (Figures S3O and S3P). Together with the data presented
in Figure 3, these results suggest that ppGpp is necessary but
insufficient for stringent inhibition of rRNA synthesis and that
loss of the effect of ClpA on rRNA expression can be compen-
sated for by higher levels of ppGpp.
As stringent transcriptional control uses DksA in addition to
ppGpp to more effectively modulate RNAP activity [30], we
tested whether DksA played a role in how ClpA affects the strin-
gent response. Since DksA is a known substrate of ClpXP [31],
we hypothesized that ClpA loss could enhance DksA degrada-
tion by ClpXP because ClpX would no longer have to compete
with ClpA for ClpP, which would lead to attenuated stringent
transcriptional control [30]. We expressed dksA off its natural
promoter to increase dksA expression levels in DrelA and DclpA.
When persister levels were enumerated, complemented DdksA
exhibited persister formation comparable to wild-type with a
control vector, and increased levels of DksA in DrelA could not
restore persister formation (Figures S3Q and S3R), which
demonstrated that ppGpp was required for persister formation.
For DclpA, dksA overexpression partially restored persister for-
mation (Figure S3S) to levels that were analogous to expressing
relA0 inDclpA. This further confirmed ClpA’s involvement in strin-
gent transcriptional control and implicated DksA as an important
mediator of our pathway. To provide further support for a mech-
anism where the impact of DclpA depends on the activity of
ClpXP, we tested whether DclpP or DclpX would restore
persister formation to DclpA. For DclpADclpP and DclpADclpX,
we found persister formation comparable to that of wild-type,
which provided support that the Clp system impacted persister
formation through DksA (Figures S3T and S3U). Interestingly,
these data demonstrate that DrelA, DssrA, and DclpA eliminated
persister formation through a common mechanism of an attenu-
ated stringent response.
Stringent Response Leads to Ampicillin Persistence
through Broad Shutdown of Peptidoglycan Biosynthesis
Given the essentiality of RelA and the impact of trans-translation
and ClpA on stringent control during diauxie, we sought to iden-
tify how the stringent response can affect ampicillin’s primary2094 Current Biology 25, 2090–2098, August 17, 2015 ª2015 Elsevietarget, the penicillin-binding proteins (PBPs) [32], which are
essential enzymes of PGB. Previously, ppGpp was found to
inhibit phospholipid synthesis at the site of PlsB, which led to
PGB inhibition and ampicillin tolerance [33]. Overexpression of
plsB restored ampicillin sensitivity under those conditions [16];
however, plsB overexpression here exhibited persister formation
that was comparable to overexpression of the control protein,
GFP (Figure S4).
Beyond inhibition of phospholipid biosynthesis, many studies
have linked the stringent response to various aspects of PGB
[34–37]. With a plethora of mechanisms through which the strin-
gent response can perturb PGB, we tested whether persistence
to fosfomycin, an inhibitor of the initial step of PGB (MurA) [38],
also increased upon carbon source transitions. If the transi-
tion-dependent stringent response was leading to a broad inhi-
bition of PGB, then persisters to antibiotics targeting elements
at both the beginning (MurA) and end (PBPs) of the pathway
would form persisters in a RelA-dependent manner. In addition,
we tested carbenicillin, a b-lactam that targets multiple PBPs,
and cefsulodin, a cephalosporin that targets PBP1 [32]. Wild-
type cells treated with fosfomycin, carbenicillin, or cefsulodin ex-
hibited 20-fold increases in persisters from the carbon source
transition, which were comparable to those observed for ampi-
cillin-treated cells (Figures 4A–4C). When DrelA was treated
with fosfomycin, carbenicillin, or cefsulodin, persister formation
was not observed, which was analogous to results with ampi-
cillin (Figures 4D–4F). We then studied persister formation
when treating with both ampicillin and fosfomycin to inhibit the
beginning and end of PGB simultaneously. Since fosfomycin
produced lower absolute persister levels than ampicillin under
all conditions (Figures 4A and 4D), we expected that the co-treat-
ment would yield persister levels identical to fosfomycin treat-
ment if the stringent response broadly inhibited PGB, whereas
if heterogeneous inhibition was present, the co-treatment would
yield persister levels far below that of the most potent single
treatment. In co-treated samples, persister formation was equiv-
alent to that with fosfomycin (Figure 4G). These data provide
evidence that the diauxie-initiated stringent response facilitates
formation of persisters to cell-wall targeting antibiotics through
broad inhibition of PGB.
A Single Metabolic Stress Generates Persister
Heterogeneity
We elucidated two antibiotic-specific persister formation path-
ways originating from a single stress and next sought to identify
which components overlapped and which were distinct. Ofloxa-
cin persister formation was mediated by RelA, SpoT, DksA, and
NAPs, whereas ampicillin persister formation required RelA,
trans-translation, and ClpA through a mechanism that involved
DksA. RelA-dependent ppGpp synthesis was important for
both formation pathways, but its role was more significant in
ampicillin persister formation. Since removing one ppGpp
synthase, RelA, can eliminate ampicillin persister formation,
whereas removal of both RelA and SpoT are needed to eliminate
ofloxacin formation, we hypothesized that higher ppGpp con-
centrations are needed to generate ampicillin persisters. To
test this hypothesis, we used controlled expression of relA0 un-
der an IPTG-inducible promoter to vary levels of ppGpp produc-
tion. We confirmed that intracellular ppGpp levels increasedr Ltd All rights reserved
Figure 4. Stringent Response Broadly Inhibits Peptidoglycan
Biosynthesis during Diauxie
(A–C) Wild-type cells exhibited fosfomycin (FOS) (A), carbenicillin (CARB) (B),
and cefsulodin (CEF) (C) persister generation comparable to that of ampicillin.
(D–F) Persister formation was eliminated in DrelA when challenged with FOS
(D), CARB (E), or CEF (F), which was analogous to ampicillin.
(G) Co-treated cells exhibited persister levels comparable to FOS.
Error bars indicate SEM. See also Figure S4.
Figure 5. ppGpp Produces Persister Heterogeneity
RelA0 expression was induced in wild-type carrying pSA19 with specified
IPTG concentrations. Cells were cultured for 3 hr and then challenged with
200 mg/mL ampicillin or 5 mg/mL ofloxacin. Survival fractions after 5 hr of
treatment are shown. Error bars indicate SEM. See also Figure S5.
Current Biology 25, 2090–according to the level of induction of relA0 (Figures S5A and S5B).
Uponmild induction of relA0 (25 mM IPTG), no persister formation
for either antibiotic was observed compared to the uninduced
control. Upon increasing the inducer concentration, we
observed antibiotic-specific persister formation (Figures 5 and
S5C). For ofloxacin, from 25 mM to 100 mM IPTG, persister levels
increased by 600-fold, and those levels were maintained at
higher IPTG levels, which resembled switch-like, threshold-
based behavior. For ampicillin, persister levels gradually
increased from 25 mM to 1,000 mM IPTG. These results demon-
strate that ppGpp can produce unique levels of antibiotic toler-
ance, which is a distinction likely due to its differential impact
on cellular physiology and ultimately the antibiotics’ primary
targets.
We also sought to genetically test whether ofloxacinmediators
participate in the ampicillin pathway and vice versa. Deletion of
NAPs, Dfis and DhupB, which were identified as mediators of
ofloxacin persister formation [12], showed ampicillin persister
formation analogous to wild-type (Figures 6A and 6B), demon-
strating that NAPs are mediators unique to the ofloxacin
pathway.
We next explored whether the mediators identified in the
ampicillin pathway are active in ofloxacin persister formation.
Though bothmechanismswere delineated from a carbon source
transition, themedia conditions were different when studying the
ofloxacin pathway. For ofloxacin persisters, since we discovered
the presence of both a growth-arrest-dependent and a cAMP-
ppGpp pathway, in order to study the latter, we supplemented
media with trace aa to eliminate growth arrest during the carbon
transition [12]. In contrast, data presented here did not suggest
the presence of multiple pathways for ampicillin persister forma-
tion (Figure 2D), so aa-supplemented media was not required.
Therefore, we tested DssrA, DsmpB, and DclpA for their role in
ofloxacin persister formation in the aa-supplemented media.
While DclpA exhibited persister formation similar to wild-type,
DssrA and DsmpB exhibited strongly attenuated formation (Fig-
ures 6C–6E). These results indicated that ClpA is unique to the
ampicillin pathway, whereas trans-translation is an important
component of both mechanisms. Since we have shown that
trans-translation works through the stringent response in diauxic
media, we analyzed whether DssrA in the aa-supplemented
media also possesses defective stringent control by measuring
ppGpp and using a transcriptional ppGpp reporter, pUA66-
PwrbA-gfp [12]. Prior to ppGpp measurements, we confirmed2098, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2095
Figure 6. Impact of Mediators on Ampicillin and Ofloxacin Persister
Formation
(A and B) Cells were grown in minimal media and challenged with 200 mg/mL
ampicillin. Dfis (A) and DhupB (B) demonstrated persister formation similar to
wild-type.
(C–E) Cells were grown in aa-supplemented media and challenged with
5 mg/mL ofloxacin. DclpA (C) exhibited persister formation that was compa-
rable to wild-type, whereas DssrA (D) and DsmpB (E) exhibited significantly
reduced persister formation.
Error bars indicate SEM. Significance was assessed using the null hypothesis
that the mean fold change in persisters for the mutant was equal to the mean
fold change in persisters for wild-type. See also Figure S6.that persister formation phenotypes in MOPS media with trace
aa were analogous to those found in M9 with trace aa (Figures
S6A–S6C). At the transition, DclpA possessed ppGpp levels
analogous towild-type (Figures S6D and S6E), and after the tran-
sition, wild-type and DclpA displayed comparable induction of
the ppGpp reporter in the glucose-fumarate media compared
to the glucose-only control (Figures S6F and S6G). Similar to2096 Current Biology 25, 2090–2098, August 17, 2015 ª2015 Elseviediauxic conditions, DssrA showed significantly lower ppGpp
levels at the transition compared to wild-type (Figures S6D and
S6E) and exhibited no increase in fluorescence using our ppGpp
reporter (Figure S6H), which was comparable to previous results
withDrelADspoT [12]. These data demonstrated thatDclpA does
not influence ppGpp or the stringent response when trace aa are
present, whereas DssrA affects ppGpp production and stringent
transcriptional control upon the carbon source transition.
DISCUSSION
We have discovered that a single metabolic stress, carbon
source transitions, initiates persister formation cascades that
lead to persister heterogeneity. Here, we delineated an ampicillin
persister formation pathway from source of stress, glucose
exhaustion, to the activation of a RelA-dependent stringent
response that required trans-translation and ClpA through a
mechanism that involved DksA, which led to widespread, strin-
gent-dependent inhibition of PGB. Common factors between
the different pathways were the stringent response, building
upon the growing evidence of ppGpp as a central regulator of
persistence [2, 5, 12, 22, 23, 39, 40], and trans-translation, which
has recently been linked to persistence [41].
Several studies have explored the relationship between the
stringent response and persistence [2, 5, 12, 22–24, 40]. Nguyen
and colleagues studied biofilm persistence ofPseudomonas aer-
uginosa and E. coli under starvation conditions [24], whereas
Fung and colleagues analyzed the role of the stringent response
in antibiotic tolerance in response to various nutrient deple-
tions [5]. These studies not only demonstrated a role for the
stringent response in persister formation due to nutritional per-
turbations but also provided data that the role of the stringent
response in producing antibiotic tolerance is complex and likely
dependent on the antibiotic’s primary mode of action. In our pre-
vious work and the data presented here, we provided evidence
that the stringent response signals drug-specific formation
mechanisms in response to carbon source transitions. This het-
erogeneity can arise from the metabolite’s ability to inhibit DNA
replication and cell division machinery on different timescales
and/or to different degrees [42] through both direct interactions
and stringent transcriptional control. We found uniquemediators
to exist, and the concentrations of those proteins in a single cell
may also play a role in survival to either ampicillin or ofloxacin.
For example, a cell may possess sufficient ppGpp levels and
have favorable NAP concentrations but possess an unfavorable
ClpA concentration, making the cell susceptible to ampicillin but
tolerant to ofloxacin. Therefore, while ppGpp and a functional
stringent response are essential to formation, other factors,
perhaps in combination, play a role in determining the fate of a
particular cell upon antibiotic treatment.
We found that trans-translation is essential to both persister
formation cascades, and it has previously been implicated in
persister survival to a variety of antibiotics and stresses [41].
Our data add to this knowledge by providing evidencewith direct
ppGpp quantification, qPCR, and a ppGpp transcriptional re-
porter that trans-translation is needed for cells to exhibit normal
stringent control during a carbon source transition. This require-
ment was an interesting discovery, and how this system exerts
its effects will be the topic of a future study.r Ltd All rights reserved
Significant evidence has emerged that persisters can no
longer be regarded as a homogenous multidrug-tolerant entity.
The first notion of varied persister populations came from Bala-
ban and colleagues who categorized persister cells as either
type I, non-growing cells derived from stationary phase, or
type II, cells that have reduced growth rates [3]. Subsequent
studies analyzing persister formation in response to toxin
overexpression and genetic deletions and in clinical isolates
demonstrated antibiotic-dependent variability in persister levels,
which suggested that activity of individual cellular processes
dictated tolerance to a particular antibiotic and persister
populations are not comprised of a single multidrug-tolerant
population [6–8, 43, 44]. Here, we provided evidence that a
single metabolic stress can generate heterogeneous subpopula-
tions of persisters, which can present a significant therapeutic
challenge. However, we demonstrated that by comparing forma-
tion pathways, shared mediators exist, and thus, a common
strategy can be used to eliminate formation of different per-
sisters. We discovered that the stringent response and trans-
translation are common to both ampicillin and ofloxacin persister
formation, and inhibitors of these systems are currently being
explored [45, 46].
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions
Bacterial strains and plasmids are listed in Table S2, and details on their con-
struction are described in the Supplemental Experimental Procedures and
Table S3. M9 minimal medium was used in all experiments except during
ppGpp quantification where MOPS minimal medium was used since
phosphate concentrations need to be limited. For carbon source transition ex-
periments, 0.5 mM glucose plus 24 mM carbon of the secondary carbon
source were used. Single carbon source experiments contained 27 mM
carbon. The aa supplement added to specific experiments was described pre-
viously [12]. Additional details are provided in the Supplemental Experimental
Procedures.
Persistence Measurements
Persistence wasmeasured by determining the number of colony-forming units
(CFUs) per mL after exposure to 200 mg/mL ampicillin, 200 mg/mL fosfomycin,
200 mg/mL carbenicillin, 200 mg/mL cefsulodin, or 5 mg/mL ofloxacin. At spec-
ified cell densities or times, 500 mL aliquots of culture were removed, treated
with antibiotic, and incubated at 37C and 250 rpm. At the designated time
point, samples were collected by centrifugation (3 min, 15,000 rpm), washed
with PBS, and serially diluted in PBS, and 10 mL was spotted onto LB agar.
Plates were incubated for 16 hr at 37Cand CFUsweremeasured. 20–100 col-
onies were counted for each data point unless noted otherwise.
Statistical Analysis
Statistical significance was assessed using two-tailed t tests with unequal var-
iances. Persister data obtained from the 5 hr post-antibiotic treatment CFU/mL
measurements were statistically analyzed, and the threshold for significance
was set to p < 0.05.
Additional Assays
Details for experiments involving cAMP, SHX, and CAM, ppGpp quantification,
qPCR, and RelA0 overexpression are provided in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cub.2015.06.034.Current Biology 25, 2090–AUTHOR CONTRIBUTIONS
S.M.A. conducted experiments. S.M.A. and M.P.B. designed experiments,
analyzed data, and wrote the manuscript.
ACKNOWLEDGMENTS
We thank Michael Cashel, Thomas Silhavy, A. James Link, Christina DeCoste,
and John Grady for experimental assistance and the National BioResource
Project (NIG, Japan) for distribution of the Keio collection. This research was
supported by the NSF (S.M.A.: GRF grant), Department of the Army
(W81XWH-12-2-0138), and Princeton University (M.P.B.: startup funds;
S.M.A.: Center for Health and Wellness US Healthcare and Health Policy
Research Grant). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Received: February 12, 2015
Revised: May 31, 2015
Accepted: June 16, 2015
Published: August 6, 2015
REFERENCES
1. Lewis, K. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357–372.
2. Maisonneuve, E., Castro-Camargo, M., and Gerdes, K. (2013). (p)ppGpp
controls bacterial persistence by stochastic induction of toxin-antitoxin
activity. Cell 154, 1140–1150.
3. Balaban, N.Q., Merrin, J., Chait, R., Kowalik, L., and Leibler, S. (2004).
Bacterial persistence as a phenotypic switch. Science 305, 1622–1625.
4. Maisonneuve, E., and Gerdes, K. (2014). Molecular mechanisms underly-
ing bacterial persisters. Cell 157, 539–548.
5. Fung, D.K., Chan, E.W., Chin, M.L., and Chan, R.C. (2010). Delineation of a
bacterial starvation stress response network which can mediate antibiotic
tolerance development. Antimicrob. Agents Chemother. 54, 1082–1093.
6. Ma, C., Sim, S., Shi, W., Du, L., Xing, D., and Zhang, Y. (2010). Energy pro-
duction genes sucB and ubiF are involved in persister survival and toler-
ance to multiple antibiotics and stresses in Escherichia coli. FEMS
Microbiol. Lett. 303, 33–40.
7. Li, Y., and Zhang, Y. (2007). PhoU is a persistence switch involved in
persister formation and tolerance to multiple antibiotics and stresses in
Escherichia coli. Antimicrob. Agents Chemother. 51, 2092–2099.
8. Keren, I., Shah, D., Spoering, A., Kaldalu, N., and Lewis, K. (2004).
Specialized persister cells and the mechanism of multidrug tolerance in
Escherichia coli. J. Bacteriol. 186, 8172–8180.
9. Vega, N.M., Allison, K.R., Khalil, A.S., and Collins, J.J. (2012). Signaling-
mediated bacterial persister formation. Nat. Chem. Biol. 8, 431–433.
10. Allison, K.R., Brynildsen, M.P., and Collins, J.J. (2011). Heterogeneous
bacterial persisters and engineering approaches to eliminate them. Curr.
Opin. Microbiol. 14, 593–598.
11. Orman, M.A., and Brynildsen, M.P. (2013). Dormancy is not necessary or
sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57,
3230–3239.
12. Amato, S.M., Orman, M.A., and Brynildsen, M.P. (2013). Metabolic control
of persister formation in Escherichia coli. Mol. Cell 50, 475–487.
13. Traxler, M.F., Chang, D.E., and Conway, T. (2006). Guanosine 30,50-bispyr-
ophosphate coordinates global gene expression during glucose-lactose
diauxie in Escherichia coli. Proc. Natl. Acad. Sci. USA 103, 2374–2379.
14. Tosa, T., and Pizer, L.I. (1971). Biochemical bases for the antimetabolite
action of L-serine hydroxamate. J. Bacteriol. 106, 972–982.
15. Eng, R.H., Padberg, F.T., Smith, S.M., Tan, E.N., and Cherubin, C.E.
(1991). Bactericidal effects of antibiotics on slowly growing and
nongrowing bacteria. Antimicrob. Agents Chemother. 35, 1824–1828.
16. Rodionov, D.G., and Ishiguro, E.E. (1995). Direct correlation between over-
production of guanosine 30,50-bispyrophosphate (ppGpp) and penicillin
tolerance in Escherichia coli. J. Bacteriol. 177, 4224–4229.2098, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2097
17. Li, X., Yagi, M., Morita, T., and Aiba, H. (2008). Cleavage of mRNAs and
role of tmRNA system under amino acid starvation in Escherichia coli.
Mol. Microbiol. 68, 462–473.
18. Keiler, K.C. (2008). Biology of trans-translation. Annu. Rev. Microbiol. 62,
133–151.
19. Gottesman, S., Roche, E., Zhou, Y., and Sauer, R.T. (1998). The ClpXP and
ClpAP proteases degrade proteins with carboxy-terminal peptide tails
added by the SsrA-tagging system. Genes Dev. 12, 1338–1347.
20. Choy, J.S., Aung, L.L., and Karzai, A.W. (2007). Lon protease degrades
transfer-messenger RNA-tagged proteins. J. Bacteriol. 189, 6564–6571.
21. Maisonneuve, E., Shakespeare, L.J., Jørgensen, M.G., and Gerdes, K.
(2011). Bacterial persistence by RNA endonucleases. Proc. Natl. Acad.
Sci. USA 108, 13206–13211.
22. Germain, E., Castro-Roa, D., Zenkin, N., and Gerdes, K. (2013). Molecular
mechanism of bacterial persistence by HipA. Mol. Cell 52, 248–254.
23. Korch, S.B., Henderson, T.A., and Hill, T.M. (2003). Characterization of the
hipA7 allele of Escherichia coli and evidence that high persistence is gov-
erned by (p)ppGpp synthesis. Mol. Microbiol. 50, 1199–1213.
24. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K.,
McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011). Active
starvation responses mediate antibiotic tolerance in biofilms and
nutrient-limited bacteria. Science 334, 982–986.
25. Lazzarini, R.A., Cashel, M., and Gallant, J. (1971). On the regulation of
guanosine tetraphosphate levels in stringent and relaxed strains of
Escherichia coli. J. Biol. Chem. 246, 4381–4385.
26. Amato, S.M., and Brynildsen, M.P. (2014). Nutrient transitions are a source
of persisters in Escherichia coli biofilms. PLoS ONE 9, e93110.
27. Baracchini, E., and Bremer, H. (1988). Stringent and growth control of
rRNA synthesis in Escherichia coli are both mediated by ppGpp. J. Biol.
Chem. 263, 2597–2602.
28. Ryals, J., Little, R., and Bremer, H. (1982). Control of rRNA and tRNA syn-
theses in Escherichia coli by guanosine tetraphosphate. J. Bacteriol. 151,
1261–1268.
29. Schreiber, G., Metzger, S., Aizenman, E., Roza, S., Cashel, M., andGlaser,
G. (1991). Overexpression of the relA gene in Escherichia coli. J. Biol.
Chem. 266, 3760–3767.
30. Paul, B.J., Barker, M.M., Ross, W., Schneider, D.A., Webb, C., Foster,
J.W., and Gourse, R.L. (2004). DksA: a critical component of the transcrip-
tion initiation machinery that potentiates the regulation of rRNA promoters
by ppGpp and the initiating NTP. Cell 118, 311–322.
31. Flynn, J.M., Neher, S.B., Kim, Y.I., Sauer, R.T., and Baker, T.A. (2003).
Proteomic discovery of cellular substrates of the ClpXP protease reveals
five classes of ClpX-recognition signals. Mol. Cell 11, 671–683.
32. Curtis, N.A., Orr, D., Ross, G.W., and Boulton, M.G. (1979). Affinities of
penicillins and cephalosporins for the penicillin-binding proteins of
Escherichia coli K-12 and their antibacterial activity. Antimicrob. Agents
Chemother. 16, 533–539.2098 Current Biology 25, 2090–2098, August 17, 2015 ª2015 Elsevie33. Heath, R.J., Jackowski, S., and Rock, C.O. (1994). Guanosine tetraphos-
phate inhibition of fatty acid and phospholipid synthesis in Escherichia coli
is relieved by overexpression of glycerol-3-phosphate acyltransferase
(plsB). J. Biol. Chem. 269, 26584–26590.
34. Ishiguro, E.E., and Ramey, W.D. (1980). Inhibition of in vitro peptidoglycan
biosynthesis in Escherichia coli by guanosine 50-diphosphate 30-diphos-
phate. Can. J. Microbiol. 26, 1514–1518.
35. Kusser, W., and Ishiguro, E.E. (1985). Involvement of the relA gene in the
autolysis of Escherichia coli induced by inhibitors of peptidoglycan biosyn-
thesis. J. Bacteriol. 164, 861–865.
36. Goodell, W., and Tomasz, A. (1980). Alteration of Escherichia coli murein
during amino acid starvation. J. Bacteriol. 144, 1009–1016.
37. Kanjee, U., Ogata, K., and Houry, W.A. (2012). Direct binding targets of the
stringent response alarmone (p)ppGpp. Mol. Microbiol. 85, 1029–1043.
38. Falagas, M.E., Kastoris, A.C., Kapaskelis, A.M., and Karageorgopoulos,
D.E. (2010). Fosfomycin for the treatment of multidrug-resistant, including
extended-spectrum beta-lactamase producing, Enterobacteriaceae in-
fections: a systematic review. Lancet Infect. Dis. 10, 43–50.
39. Amato, S.M., Fazen, C.H., Henry, T.C., Mok, W.W.K., Orman, M.A.,
Sandvik, E.L., Volzing, K.G., and Brynildsen, M.P. (2014). The role of meta-
bolism in bacterial persistence. Front Microbiol 5, 70.
40. Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban, N.Q., and Glaser, G.
(2013). HipA-mediated antibiotic persistence via phosphorylation of the
glutamyl-tRNA-synthetase. Nat. Commun. 4, 3001.
41. Li, J., Ji, L., Shi, W., Xie, J., and Zhang, Y. (2013). Trans-translation medi-
ates tolerance to multiple antibiotics and stresses in Escherichia coli.
J. Antimicrob. Chemother. 68, 2477–2481.
42. Schreiber, G., Ron, E.Z., and Glaser, G. (1995). ppGpp-mediated regula-
tion of DNA replication and cell division in Escherichia coli. Curr.
Microbiol. 30, 27–32.
43. Va´zquez-Laslop, N., Lee, H., and Neyfakh, A.A. (2006). Increased persis-
tence in Escherichia coli caused by controlled expression of toxins or other
unrelated proteins. J. Bacteriol. 188, 3494–3497.
44. Goneau, L.W., Yeoh, N.S., MacDonald, K.W., Cadieux, P.A., Burton, J.P.,
Razvi, H., and Reid, G. (2014). Selective target inactivation rather than
global metabolic dormancy causes antibiotic tolerance in uropathogens.
Antimicrob. Agents Chemother. 58, 2089–2097.
45. Wexselblatt, E., Oppenheimer-Shaanan, Y., Kaspy, I., London, N.,
Schueler-Furman, O., Yavin, E., Glaser, G., Katzhendler, J., and Ben-
Yehuda, S. (2012). Relacin, a novel antibacterial agent targeting the
Stringent Response. PLoS Pathog. 8, e1002925.
46. Ramadoss, N.S., Alumasa, J.N., Cheng, L., Wang, Y., Li, S., Chambers,
B.S., Chang, H., Chatterjee, A.K., Brinker, A., Engels, I.H., and Keiler,
K.C. (2013). Small molecule inhibitors of trans-translation have broad-
spectrum antibiotic activity. Proc. Natl. Acad. Sci. USA 110, 10282–10287.r Ltd All rights reserved
